There is progressive evolution in the use of inhalable drug delivery systems (DDSs) for lung
cancer therapy. The inhalation route offers many advantages, being non-invasive method of …

Objective Various nanoparticles have been designed and tested in order to select optimal
carriers for the inhalation delivery of anticancer drugs to the lungs. Methods The following …

Colloidal drug delivery systems have been extensively investigated as drug carriers for the
application of different drugs via different routes of administration. Systems, such as solid …

Targeted delivery of drug molecules to organs or special sites is one of the most challenging
research areas in pharmaceutical sciences. By developing colloidal delivery systems such …

The lung is an attractive target for drug delivery due to noninvasive administration via
inhalation aerosols, avoidance of first-pass metabolism, direct delivery to the site of action …

Introduction: Pulmonary route is one of the preferred routes for the administration of
therapeutically active agents for systemic as well as localized delivery. Chronic obstructive …

We are providing an update to our previously published review paper on inhaled
nanoparticles, thus updating with the most recent reports in the literature. The field of …

Considering the challenges associated with conventional chemotherapy, targeted and local
delivery of chemotherapeutics via nanoparticle (NP) carriers to the lungs is an emerging …

Importance of the field: Drug delivery to lungs appears to be an attractive proposition on
account of the large surface area of the alveolar region; it provides tremendous opportunities …

The lungs are an attractive route for non-invasive drug delivery with advantages for both
systemic and local applications. Incorporating therapeutics with polymeric nanoparticles …